Effectiveness of Rosuvastatin plus Colchicine, Emtricitabine/ Tenofovir and a combination of them in Hospitalized Patients with SARS Covid-19.
| dc.contributor.author | Instituto Global para la Excelencia en el Cuidado de la Salud Keralty | |
| dc.date.accessioned | 2026-04-17T02:33:19Z | |
| dc.date.available | 2026-04-17T02:33:19Z | |
| dc.date.issued | 2022 | |
| dc.format | text | |
| dc.identifier.uri | https://repositorio.unisanitas.edu.co/handle/123456789/1289 | |
| dc.language.iso | en | |
| dc.publisher | Keralty | |
| dc.relation.ispartof | The Lancet | |
| dc.relation.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686571/ | |
| dc.title | Effectiveness of Rosuvastatin plus Colchicine, Emtricitabine/ Tenofovir and a combination of them in Hospitalized Patients with SARS Covid-19. | |
| dc.type | Publicacion |